Navigation Links
Patient-Centered Outcomes Research Institute announces 2 awards to Group Health
Date:12/27/2012

Seattle, WAGroup Health has been approved for two research awards from the Patient-Centered Outcomes Research Institute (PCORI) to study ways to improve care for back pain and to connect patients with community resources. The projects are part of a portfolio of patient-centered comparative clinical effectiveness research that addresses PCORI's National Priorities for Research and Research Agenda.

Authorized by the Affordable Care Act, PCORI is an independent nonprofit dedicated to funding comparative clinical effectiveness research. In its first cycle of funding, with 25 projects approved nationwide, PCORI awarded two to Washington state, both to Group Health, a "learning health system" where research and care delivery inform each other:

Group Health Research Institute (GHRI) Senior Investigator Dan Cherkin, PhD, will lead a project on back pain, which is an extremely common condition. The project will develop and test a tool for finding out which patients are at risk for long-term back pain and which evidence-based treatments are most likely to help them based on their levels of risk. The tool will be based on one that was developed and found effective in England for tailoring treatment type and intensity to the needs of each individual patient with back pain. Many health care systems have expressed interest in using this tool in the United States, but Group Health will be the first to do so. Patients and health care providers will be involved in adapting the tool to be user-friendlyand will test and evaluate it in Group Health primary care clinics. Dr. Cherkin also directs Bastyr University Research Institute. His collaborators on this project will be Group Health Assistant Medical Director Martin Levine, MD; Research Associate Clarissa Hsu, PhD; Associate Investigator Andrea Cook, PhD; Senior Investigator Karen Sherman, PhD, MPH; and Research Associate Ben Balderson, PhD. Other significant contributors will be Group Health Director of Strat
'/>"/>

Contact: Rebecca Hughes
hughes.r@ghc.org
206-287-2055
Group Health Research Institute
Source:Eurekalert  

Page: 1 2 3 4

Related medicine news :

1. The price tag on a patient-centered medical home
2. Ability to metabolize tamoxifen affects breast cancer outcomes, Mayo Clinic-led study confirms
3. Renaissance Physician Organization Leading Effort with Greater Houston Healthconnect to Enhance Care Coordination and Patient Outcomes
4. Lifestyle changes linked to better outcomes after peripheral intervention
5. Palliative care improves outcomes for seniors
6. New stem cell research, transplant strategies show promise to improve outcomes, reduce complications
7. Studies challenge standards to improve treatment outcomes for patients with clotting disorders
8. Studies assess genetics, modified treatment to improve outcomes, reduce toxicity
9. The effect of treating institution on outcomes in head and neck cancer
10. New tumor tracking technique may improve outcomes for lung cancer patients
11. First-of-its-kind program improves outcomes for seniors admitted for trauma
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Patient-Centered Outcomes Research Institute announces 2 awards to Group Health
(Date:4/27/2015)... (PRWEB) April 27, 2015 Douglas Fitzpatrick ... help his clients feel secure, but also helps secure homes ... 7 p.m., Douglas will be manning a booth at the ... Lausche Building, 717 E. 17th Ave., Columbus, Ohio. , ... event that will feature hundreds of adoptable pets from more ...
(Date:4/27/2015)... April 27, 2015 FMC Corporation’s Health ... its wide range of market leading ingredients and solutions ... in Geneva, Switzerland. Vitafoods Europe 2015 expects to host ... showcasing the latest research in such areas as digestive ... , FMC Health and Nutrition’s booth will feature its ...
(Date:4/27/2015)... 27, 2015 A' Design Award and ... SMRT IMAGE Lumica by Boombang Inc Design Team has ... Design Award in Scientific Instruments, Medical Devices and ... SMRT IMAGE Lumica, Boombang Inc Design Team, the creative ... Lumica explained “SMRT Image Lumica is a two-way communication ...
(Date:4/27/2015)... April 27, 2015 Cannabix Technologies Inc. ... that Mr. Rocco Iannapollo has become an Advisor to ... for law enforcement and workplace testing. Mr. Iannapollo is ... 20 years of experience in the oil and gas ... experience with supplier, employer, and DOT compliance policies and ...
(Date:4/27/2015)... 2015 Ticket Down is a reputable ... Alpine Valley Music Theatre and the Isleta Amphitheater. ... New Mexico area can celebrate because their favorite performer ... Buffett will be performing alongside legendary performers, Huey ... stops during the summer and fall months of 2015 ...
Breaking Medicine News(10 mins):Health News:Farmers Insurance Agent Douglas Fitzpatrick Ensures Pets Find Homes 2Health News:FMC Health and Nutrition to Feature Epax® Brand Omega-3 Ingredients at Vitafoods Europe 2015 2Health News:Boombang Inc Design Team wins Platinum in A' Medical Product Design Awards 2Health News:Rocco Iannapollo becomes an Advisor to Cannabix Technologies 2Health News:Rocco Iannapollo becomes an Advisor to Cannabix Technologies 3Health News:Rocco Iannapollo becomes an Advisor to Cannabix Technologies 4Health News:Cheap Jimmy Buffett Tickets at Alpine Valley Music Theatre in Elkhorn, WI and at Isleta Amphitheater in Albuquerque, NM Now on Sale at TicketDown.com 2
... deficiency is associated with arterial stiffness, a risk factor for ... new study accepted for publication in The Endocrine Society,s www.endo-society.org ... units (IU) per day had a decrease in central arterial ... humans with most of our body,s requirement of vitamin D, ...
... By Steven Reinberg HealthDay Reporter , WEDNESDAY, ... prostate cancer vaccine extended the lives of men with ... study shows. The vaccine, called Provenge (sipuleucel-T), improved ... and involved less toxicity than chemotherapy. However, with a ...
... HealthDay Reporter , WEDNESDAY, July 28 (HealthDay News) -- ... warning of Parkinson,s disease and other neurological disorders, new research ... condition in which people violently act out their dreams during ... to develop Parkinson,s and related neurological disorders as much as ...
... prostate cancer, especially the more aggressive and dangerous forms that ... they age than men who stay free of the disease, ... on Aging (NIA), part of the National Institutes of Health. ... of Urology International , could help scientists gain a better ...
... HealthDay Reporter , TUESDAY, July 27 (HealthDay News) -- The ... their 40s is due more to the technology itself than ... study. For years, experts have known that mammography,s performance ... and they,ve placed much of the blame on the notion ...
... adults are more likely to use walkers, canes and other ... risk of using them incorrectly, according to new research from ... obesity is an epidemic for this population as well," said ... the project,s lead author. "This research shows that if obesity ...
Cached Medicine News:Health News:Vitamin D deficiency linked to arterial stiffness in black teens 2Health News:Vaccine Boosts Survival for Men With Advanced Prostate Cancer: Study 2Health News:Vaccine Boosts Survival for Men With Advanced Prostate Cancer: Study 3Health News:Sleep Disorder May Help Predict Parkinson's Decades Earlier 2Health News:Sleep Disorder May Help Predict Parkinson's Decades Earlier 3Health News:Dense bones linked to raised risk for prostate cancer 2Health News:Technology May Explain Mammogram's Poorer Performance in Younger Women 2Health News:Technology May Explain Mammogram's Poorer Performance in Younger Women 3Health News:Study: Weight issues move up need for walkers, canes, other devices 2Health News:Study: Weight issues move up need for walkers, canes, other devices 3
(Date:4/27/2015)... FORT WORTH, Texas , April 27, 2015 ... microscopy market is segmented based on type, application, and geography ... valued at $728.9 million in 2014, and is expected to ... through the forecast period. Browse through the TOC ... an idea of the in-depth analysis provided. This also provides ...
(Date:4/27/2015)... 2015 Bronstein, Gewirtz & Grossman, LLC is ... securities of Celladon Corporation ("Celladon" or the "Company") (NasdaqGM: ... Peretz Bronstein or his investor relations coordinator ... The investigation concerns whether Celladon and certain ... and 20(a) of the Securities Exchange Act of 1934.  ...
(Date:4/27/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/t2mvbz/endoscopy_global ... "Endoscopy Global Market - Forecast to 2020" ... http://photos.prnewswire.com/prnh/20130307/600769) , , ,The global endoscopy market is ... growing at around 7.0% CAGR from 2014 to ... are aging population, increase in cancer, diabetes, and ...
Breaking Medicine Technology:North America Optical Microscopy Market is Expected to Reach $829.9 Million by 2019, at a CAGR of 3.0% From 2014 to 2019 2North America Optical Microscopy Market is Expected to Reach $829.9 Million by 2019, at a CAGR of 3.0% From 2014 to 2019 3SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Celladon Corporation 2Endoscopy Global Market - Forecast to 2020: Market is expected to reach approximately $43 billion with Johnson and Johnson, Olympus and Covidien Dominating 2Endoscopy Global Market - Forecast to 2020: Market is expected to reach approximately $43 billion with Johnson and Johnson, Olympus and Covidien Dominating 3
... Nov. 17 Mersana Therapeutics , a ... an ongoing Phase 1 study of its lead development candidate, ... were presented in a poster session at the ... in Boston, MA November 15-19, 2009. XMT-1001 is a conjugate ...
... , SEOUL, South Korea, Nov. 17 ... Securities Dealers Association Quotation System ("Arigene") (KOSDAQ: 067850), today announced ... announced merger agreement dated October 2, 2009 with Trimeris, Inc. ... of the expiration date of the tender offer being conducted ...
Cached Medicine Technology:Mersana Therapeutics Provides Clinical Update from Ongoing Phase 1 Study of XMT-1001 in Patients with Advanced Solid Tumors 2Mersana Therapeutics Provides Clinical Update from Ongoing Phase 1 Study of XMT-1001 in Patients with Advanced Solid Tumors 3Arigene Co., Ltd. Enters Into Amendment To Merger Agreement With Trimeris, Inc. 2Arigene Co., Ltd. Enters Into Amendment To Merger Agreement With Trimeris, Inc. 3Arigene Co., Ltd. Enters Into Amendment To Merger Agreement With Trimeris, Inc. 4
Severe revision options for the knee and hip...
The Natural-Hip combines the surgical simplicity of a straight stem with many of the best features of an anatomic stem....
Calcar replacement stems provide options for revision and trochanteric fractures. Revision hip surgery and trauma often require prosthetic designs that replace proximal medial calcar bone loss....
Design of the Global Advantage Shoulder for shoulder replacement surgery is based on detailed studies of the shoulder, its structure and how it works....
Medicine Products: